BRILIQUE

Film-coated tablet, 60mg
RxActive license

Active substance (INN)

ticagrelor

Pharmaceutical form

Pharmaceutical formFilm-coated tablet
Strength60mg
PackagingUkupno 56 film tableta u blisteru (4x14) u kartonskoj kutiji
ManufacturerAstraZeneca AB, Sweden
Therapeutic groupBlood and blood forming organs (B01AC24)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateApril 3, 2026

Analogs in Montenegro

10

Other medicines with the same active substance

ATIXARSORx
Film-coated tablet, 60mgKrka d.d.
ATIXARSORx
Film-coated tablet, 90mgKrka d.d.
BRILIQUERx
Film-coated tablet, 90mgAstraZeneca AB
BRIREMRx
Film-coated tablet, 60mgRemedica Ltd.
BRIREMRx
Film-coated tablet, 90mgRemedica Ltd.
ECUGRARx
Film-coated tablet, 60mgPharmaswiss d.o.o.
ECUGRARx
Film-coated tablet, 90mgPharmaswiss d.o.o.
TIKAGRELOR SKRx
Film-coated tablet, 90mgKevaro Group EOOD
TINGORARx
Film-coated tablet, 60mgAlkaloid AD Skopje
TINGORARx
Film-coated tablet, 90mgAlkaloid AD Skopje
Source: CInMED register